Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Momenta Pharma (MNTA)

Momenta Pharma (MNTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,130,097
  • Shares Outstanding, K 117,276
  • Annual Sales, $ 23,870 K
  • Annual Income, $ -290,060 K
  • 60-Month Beta 1.76
  • Price/Sales 139.10
  • Price/Cash Flow N/A
  • Price/Book 6.17

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate -0.49
  • Number of Estimates 5
  • High Estimate -0.41
  • Low Estimate -0.56
  • Prior Year -0.46
  • Growth Rate Est. (year over year) -6.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.53 +30.00%
on 03/19/20
32.98 -19.08%
on 03/04/20
-1.69 (-5.95%)
since 02/27/20
3-Month
18.50 +44.27%
on 01/03/20
34.83 -23.37%
on 02/21/20
+6.33 (+31.09%)
since 12/27/19
52-Week
9.51 +180.65%
on 07/22/19
34.83 -23.37%
on 02/21/20
+13.02 (+95.25%)
since 03/27/19

Most Recent Stories

More News
Momenta (MNTA) Down 0.3% Since Last Earnings Report: Can It Rebound?

Momenta (MNTA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MNTA : 26.69 (-5.72%)
Shares of Emergent Biosolu Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (EBS , MNTA , EGRX , CVM, BIIB )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

EGRX : 40.13 (-5.49%)
EBS : 51.22 (-10.67%)
MNTA : 26.69 (-5.72%)
Watch for Momenta Pharmace to Potentially Pullback After Gaining 1.58% Yesterday

Momenta Pharmace (NASDAQ:MNTA) traded in a range yesterday that spanned from a low of $31.17 to a high of $32.87. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high...

MNTA : 26.69 (-5.72%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (GILD , MNTA , BIIB , INCY , REGN )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

BIIB : 296.75 (-2.69%)
GILD : 72.85 (-1.37%)
MNTA : 26.69 (-5.72%)
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

Sector ETF report for PSCH

PSCH : 96.43 (-4.90%)
MNTA : 26.69 (-5.72%)
LHCG : 124.41 (-4.45%)
NEOG : 58.59 (-1.36%)
XLV : 84.99 (-2.14%)
VHT : 159.90 (-2.07%)
Momenta's (MNTA) Q4 Loss Wider than Expected, Sales Beat

Momenta (MNTA) reports mixed Q4 results, with a wider-than-expected loss and revenues beating the same.

TEVA : 7.56 (-4.30%)
REGN : 449.52 (-0.61%)
MYL : 14.88 (-4.25%)
MNTA : 26.69 (-5.72%)
Momenta Pharmaceuticals (MNTA) Reports Q4 Loss, Tops Revenue Estimates

Momenta (MNTA) delivered earnings and revenue surprises of -49.12% and 64.43%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

MNTA : 26.69 (-5.72%)
Momenta: 4Q Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Momenta Pharmaceuticals Inc. (MNTA) on Wednesday reported a loss of $86.7 million in its fourth quarter.

MNTA : 26.69 (-5.72%)
Momenta Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results

-- Reported favorable interim data from Phase 1/2 study of M254 in ITP, supporting expansion of Part B; expect to report updated data in Q2 2020 and launch additional Phase 2 study in CIDP in Q4 2020 --...

MNTA : 26.69 (-5.72%)
Momenta Pharmaceuticals to Webcast Presentation at the Cowen 40th Annual Health Care Conference

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today announced that it will...

MNTA : 26.69 (-5.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade MNTA with:

Business Summary

Momenta Pharmaceuticals is a leader in the analysis, characterization and design of complex pharmaceutical products. Their scientific foundation is a set of tools and methods that allow them to develop a deep understanding of the links between a compound's chemical structure, biological function and...

See More

Key Turning Points

2nd Resistance Point 29.20
1st Resistance Point 27.95
Last Price 26.69
1st Support Level 25.37
2nd Support Level 24.04

See More

52-Week High 34.83
Last Price 26.69
Fibonacci 61.8% 25.16
Fibonacci 50% 22.17
Fibonacci 38.2% 19.18
52-Week Low 9.51

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar